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T he pathogenesis of psoriasis, a complex disease with diverse clinical presentations and with polygenic inheritance, involves ac tivation of four important cell populations: endothelial cells, lymphocytes, kerati-nocytes, and neutroph.il s. Increasing evidence indi-
cates that T lymphocyte activation is the central feature of the 
pathogenesis of psoriasis . Histologic examination of ea.rly skin 
lesions of psoriasis show that infiltration of T lymphocytes and 
macrophages into the skin precedes the epidermal prolife ration that 
is characteristic of psoriasis, and that keratinocyte proliferation 
precedes endothelial cell activation (Parent et a/, 1990). T cell 
clones isolated from psoriasis plaques release growth factors that 
stimulate keratinocyte proliferation (Strange et al, 1993). IFN-y is 
one of the cytokines that triggers the regenerative epidermal 
phenotype in psoriasis (Strange eta/, 1993) . T he cytokin e pattern in 
lesional psoriatic skin contains IL-1 , T NF-a and -{3, and IFN-y and 
represents cytokiues released from lymphocytes, endothelial cells, 
and keratinocytes (Barker et al, 1991; Uyemura et al, 1993; Vollmer 
eta/, 1994). T he inheritance of psoriasis appears to be polygenic, 
and the association with particular HLA genotypes in psoriasis 
suggests that MHC-mediated T lymphocyte activation is involved 
in the pathogenesis of psoriasis (Baker et a/, 19S4) . The strongest 
evidence linking lymphocyte activation in psoriasis h as been de-
rived from the clinical observation that immunosuppressive drugs 
such as anti-CD3, corticosteroids, and cyclosporine A that inhibit 
T -cell activation and cytokine release are effective treatments for 
psoriasis (Gupta eta/, 1990). The most convin cing demonstration of 
this point has com e from the work of Krueger and Gottlieb, who 
demonstrated that an IL- 2-fusion toxin which eliminated activated 
IL-2 receptor (CD25) -positive T lymphocytes induced significan t 
clinical resolution of psoriasis, while at the same time eliminated the 
dermaJ and intradermal T lymphocyte populations and reversed the 
regenerative epidermal phenotype (Gottlieb cl a/ , 1995). It is also 
now believed that the elimination of lymphocyte populations by 
induction of apoptosis is a fundamental mechanism of action of 
ultraviole t Light therapy and PUV A treatrnent of psoriasis (Vallat et 
al, 1994). 
Endothelial cell activation appears to follow keratinocyte activa-
tion in psoriasis, and is induced by multiple cytokines including 
VEGF/VGF released from activated keratinocytes (Detm ar et a/, 
1994). The release of cytokines by activated lymphocytes and 
monocytes, and secondary cytokine release from fibroblasts and 
keratinocytes, may all cooperate to maintain endoth elial cell acti -
vation, and the activation ofneutrophils in psoriasis is dependent on 
release ofiL-S and perhaps other chemokines secreted by activated 
keratinocytes (Kojima eta/, 1993). 
Although it is clear that the control of lymphocyte activation is 
crucial in psoriasis, investigation of the mechanism s of lymphocyte 
activation in psoriasis has been difficult. To date, th.ree major lines 
of evidence indicate that both polyclona1 and oligoclonaJ lympho- · 
cyte activation contribute to the initiation and persistence of 
psoriasis. Compelling studies in acute guttate psoriasis have impli-
cated the superantigen streptococcal pyrogenic exotoxin C (SPEC) 
in the initiation of guttate psoriasis lesions by polyclonal superan-
tigen-driven eJ~:pansion of VB2 lymphocytes (Leung et al, 1995b). 
In contrast, the intraepidermal CDS+ T cells found in chronic 
plaque psoriasis show oligoclonal VB expansion consistent with 
classical antigen stimulation (Chang et al, 1994) . Finally, activation 
of the peripheral blood leukocytes from psoriasis patients by the 
superantigen staphylococcal enterotoxin B (SEB) and interleukin 2 
is sufficient to i11itiate psoriasis lesions in SCID mice (Boehncke et 
a/, 1996; Wrone-Srnith and Nickoloff, 1996). 
In 1993, Lewis contrasted the percentages of nine T -cell receptor 
VB (TCR VB) specificities in the peripheral blood and skin lesions 
of patients with guttate psoriasis and chronic plaque psoriasis, using 
a panel of monoclonaJ antibodies (Lewis et al, 1993). Both types of 
psoriasis showed a selective expansion ofVB2+ T lymphocytes in 
the skin lesions compared to the peripheral blood. In addition, 
cloned T lymphocytes isolated from such psoriatic lesions re-
sponded to stimulation in 11itro by streptococcal proteins (Baker eta/, 
1993). A study of acute guttate psoriasis patients by Leung et al has 
convincingly linked pharyn geal streptococcal toxins with the lym-
phocyte activation seen in guttate psoriasis lesions by demonstrating 
that streptococci isolated fro m the pharynx of patients wicl1 guttate 
psoriasis produced the superantigenic toxin SPEC, a potent stimu-
lator ofVB2+ T lymphocytes and that all patients studied had local 
expansion of VB2 + CD4 and CDS lymph ocytes in biopsies of skil1 
taken from nom1al-appearin g skin at the advan cing border of new 
skin lesions, consistent wicl1 SPEC activation (Leung et al, 199 5 b) . 
In addition, lymphocytes were cloned from the guttate skil1 lesions 
and the sequences of their TCR were analyzed, leading to the 
demonstration that there was polyclonal expansion of TCR VB2, 
consistent with superantigenic activation by the SPEC toxin iden-
tified in the patients. Studies by Leung and colleagues (Leung et al, 
1995a) have aJso dem onstrated that bacterial superantigens activate 
the expression of the skin homing receptor CLA in lymphocytes 
(Leung et al, 1995a). Taken together, these findings support the 
hypothesis that systemic lymphocyte activation by circulating SPEC 
in patients with streptococcal pharyngitis promotes cutaneous 
localiza tion of lymphocytes and may also induce further superan-
tigenic activation and expansion of SPEC-activated VB2+ lympho-
cytes in the skin , which initiate the lymphocyte-driven inflamma-
tion characteristic of psoriasis. 
C hang and colleagues (Chang eta/, 1994) analyzed the TCR VB 
use of epiderrnaJ T cells in shave biopsies of psoriatic lesions and 
showed increased expression ofVB3 and/or VB13.1 mRNA in the 
CDS+, but not CD4+, T cells in the lesions of a majm;ty of 
patients studied . Sequence analysis of complementarity-determin-
ing region 3 (CDR3) of these two VB genes from the skin 
demonstrated monoclonality or marked oligoclouality. A second 
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biopsy from the same or different lesions, performed 3.5- S months 
later in four patients , again revealed in creased clonal expansion of 
VB3 and/or VB13 .l expression and clonality. Moreove r, in three 
of the four patients, th e sam e VB CDR3 rearrangement was found 
in both biopsies, although there was no VB CDR 3 homology 
between patients. T he clonality ofVB seq uence data indicates these 
cell s are recruited and expanded i11 si/.11, and the persistence ofVB3 
and/or VB13.1-bearing CDS + T cells in lesions that did not 
undergo resolution suggests their role as effector cells, rather than 
as regulatory cells. T he consistent clonal expansion of CDS+ 
lymphocytes of limi ted VB specifi city strongl y suggests activation 
by classical antigen/TCR mechanisms, possibly driven by an 
antigen fi·om an infectious agent that cross-reacts with a normal 
epiderma l proteiJl. This scenario would be consistent with the 
l-ILA-A and - C associations described in pso ,;asis (V aldimarsson el 
a/, 1995), which are involved in CDS T-cell activation . 
Bacterial superantigens have been shown to be e!fective triggers 
in aJlim al models of psoriasis (Boe lmcke et a/ , 1996; Wrone-Smith 
a.nd Nicko loff, 1996). In the most recent, Wrone-Smith and 
Nicko lofF used IL-2 ru1d SEB to activate autologous lymphocytes 
from peripheral blood of patients with psoriasis. When these 
activated cells were injected intradermall y into autologous non-
lesional psoriatic skin grafted onto SCID mice, lesions typical of 
p sOL; asis developed , including the typical regenerative epidermal 
phenotype and intraepidermal neurophilic infi ltrates. It must also be 
noted that another animal model of psoriasis utilizes T -cell activa-
tion by minor histocompatibility mismatch without use of superan-
tigen activation (Schon et a/, 1997). 
Two papers in this issue of The ] oumal of l!west ignfi11e Dcrlllatology 
dispute the premise that polyclonal T -ce l.l activation by bacterial 
superantigens or clonal activation by classi cal antigens ar e impor-
tant in p soriasis vulgaris . Vekony eta/ (p. 5) fi:om the Departments 
of Dermatology and Biochemistry at the U!liversity of Leiceste r, 
UK studied the VB patterns in early lesions of psorias is vulgaris, 
using an improved anchored PCR approach to expand and quan-
titate the VB sequ ences in eDNA that had been reverse-transcribed 
from DNA-free RNA extracted from punch biopsies of early 
psoriasis les ions. T he VB mR.NA studied was from unseparated skin 
biopsies. The relative distribution s of particular VB i.n skin was 
contrasted with that in peripheral blood cells . The majority of 
p soria sis lesions studied showed some overexpression of certain 
TCR VB. In half of the sampl es analyzed , expanded VB formed 
greater than ten percent of the total lesion a! VB, and in these, VB2 
and VB6 predominated. Fewer than half of th e lesions showing VB 
expansion also showed clonal T-ceU activation as determined by 
complem entarity-dete rminjng region 3 (CDR3) size spectratyp-
in g. T h e authors conclude th at selectiv e amplitication of TCR 
VB species occurs in ea rly psoriasis but is not essential for the 
pathogenic process, speculating that it m ay be more important in 
the mainten an ce and expansion of lesion s. This latter point is 
hard to defend con sid e ring the animal mod e ls of psoriasis that 
u se supera ntigen- and cytokin e- ac tivated leuko cytes to initia te 
psoriasis lesions in human skin grafted on SCID mice (Wrone-
Smith , 1996). Also, expansion ofVB2 has bee n found in models 
of plaque and guttate p sori asis, sometimes with clonal , and 
som etim es with pol.yclonal, seq uences (Leung et a/, 199 5b; 
Mcnssen eta/ , 1995). 
M oss ~m d co lleagues (p. 14) fro m the Departments of Molecular 
Biology & unmunology and Genomics of the Darwin Molecular 
Corpora tio n and of the D ermatology Section of the Medical 
Service of the VA }luget Sound H ealth Care System, ru1d the 
Division o f Dermatology of the Department of MediciJl e at the 
University of Washington, Seattle, WA used a standard PC R 
approach to study the patte rns ofB-chain mRNAs obtained from 
biops.ics of psori asis patients and compared patte rn s in periphe ral 
bl ood from the same subjects. In fourteen psoriasis patients and 
six no rm al subj ects , no patte rn of overex.prcssion of particular 
VB specifi cities was observed. T he authors conclude that th e ir 
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res ults do not exclude the possibili ty of classica l or superantigen-
based mechanisms ofT - cell activation in p soriasis , but suggest 
that other aspects ofT - cell bio logy n eed to be consid e red, such 
as traffi ckin g, proliferation , co-stimulation , or responses to 
cytokines. 
These two pape rs demonstrate the difficulty in identifying clonal 
lymphocyte activation or selective VB expansion in psoriasis le-
sions, even in those lesions judged to be "early." These authors join 
others who have failed to find evidence of consistent patterns ofVB 
expansion in plaque psoriasis les ions (Sclunitt-Egenolf et al, 1991; 
Boehncke ef a/, 1995) . Based on the teclmiques used and the 
samples studied, however, the reported res ults are not surprising. ln 
the study by Leung eta/ (Leung eta/, 1995 b), VB2 overexpression 
in the dermal infiltrates of acute guttate lesions was found only in 
biopsies from as-ye t-uninvolved skin at the advancing lesional 
border, and not in the clinically deve loped lesions . T his fmding 
cl early implicates nonspecifi c recruitment of other lymphocytes 
even very early in lesion formation. Even in contact hypersensitiv-
ity, the prototype for classical antigen-driven clonal lymphocyte 
activ ation, recruitment of nonspecifi c lymphocytes by antigen-
activated clones occurs very early in the reaction, within 4S hours. 
In contact hype rsensitivity, less than one percent of the lymphocytic 
infiltrate represents antigen-specific 'lymphocytes (McCluskey eta /, 
1963; Kalish and Johnson, 1990). Even the " early" lesions (of less 
than three weeks duration) studied by Vekony et al, non specific 
recruited lymphocytes wou ld obscure any lymphocyte clones acti-
vated by antigen or superantigen. Unless such a PCR approach is 
applied to normal skin at the advan cing edge of active psoriasis 
les ions, one might weU miss early VB skewing and superantigen-
induced polyclonal activa tion . Even so, Vekon.y et a/ did find 
evidence of preferential VB2 expression in a high percentage of 
early clini cally developed psoriatic lesions. Simjlar results were 
demonstrated by other investigators (Lewis el a/, 1993; Menssen et 
a/, 1995) . T his is also consistent with the results of Bake•· el a/ 
(B aker et a/, 1993) , who were able to cloue T ce lls that 
responded to streptococca l proteiJlS from es tablished psoriasis 
p.laques . Importantl y, there arc significant technical differences 
in the methods used by Leung cl a/ (Leung et a/, 1995) and Lewis 
(Lewi s et a/, 1993) to demonstrate VB skewing ofT cells in early 
guttate psoria sis or plaque psoriasis. Both of the la tter studies 
used specific monoclonal antibodie s again st specifi c VB regions 
to de termine T-ceU repertoire . The advantage of this approa ch is 
that it is more precise than the PCR-based technologies in 
localizing the VB-positive cells and maintains the skin architec-
ture in the tissue being studied. 
Neither of the papers reported in this issue of JID isolated 
epidermal T lymphocytes or used any teclmique to selectively 
evaluate epidermal CDS+ lymphocyte mRNA, as was reported by 
Chang et al (Chang et rrl, 1994). Subsequent studies by investigators 
looking specifical.ly at isolated epidermal lymphocyte populations 
or at ep idermal mRNA specific for CDS lymphocytes have not 
found such a high expansion of VB3 and 13 .1 in epidermal T 
lymphocyte mR.NA, but still have found clonal or oligoclonal 
expansion suggesting classical antigen activation (Wei-J en Lin, 
personal communication) . O ne lesson fi:om these studies is that 
optimal identifi cation of activated lymphocyte populations within 
the larger population of recruited lymphocyte populations in 
psoriatic lymphocytic infiltrates obviously requires special selection 
of tissues or cells, and cannot be reliably detected in unsorted whole 
skin RNA extracts. 
It seems that the ideal method to identify "early" lymphocyte 
populatiollS in psoriasis would be to induce lesions by epicutaneous 
superantigen toxins, and then to study the first lymphocyte popu-
lations that appear. Our group has used this approach and has found 
that normal appearing skin in psoriasis patients reacts preferentially 
to bacterial superantigens applied to tape-abraded skin, when 
compared to normal skin in control subj ects of in patients with 
eczema. T he inflammatory lesions induced in these patients , how-
ever, seem to be more dependent on local cytokine release 
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Table I. Steps in Developm.ent of Lymphocyte 
Activation in Psoriasis" 
1. Systenuc lymphocyte activation 
2. Local accumulatio n of activated CD4+ lymphocytes" 
3. Recruitment of nonspec ifi c CD4+ lymphocytes and monocytes 
4. C lonal intraepid ermal CDS + lymphocytes 
" Sequential steps in activation : Lymp hocyte > Keratinocyte > Endothelial cell > 
Neu trophil activation. 
"May be either po l)'clonal (superantigcn activated) or clonnl/oligoclonal (classical 
antigen). 
(especially TNF) by superan tigens and less dependent on superan-
tigen-driven activation of particular VB populations (Travers et a/, 
manuscript in preparation). Additional studies by our group (Ezep-
chuk et a/, 1996) have shown that multiple bacterial proteins 
(staphylococcal superantigens, a toxin, and staphylococcal protein 
A) isolated from psoriatic and atopic dermatitis patients can induce 
release of the cm cial primary cytokine, TNF, which has been 
proposed to be a major trigger of psoriatic lesions . Our current 
hypothesis is that bacterial superantigens initiate guttate psoriasis 
lesions by systemic lymphocyte activation, by systemic cytokin.e 
release prin1ing loca l endothelial cell activation , and by intracuta-
neous lymphocyte activation by superantigen-released cytoki.nes or 
ped1aps directly by superantigens. 
We agree with Moss et al that cytokines and their effects on 
lymphocyte activation and trafficking are crucial in initiation and 
maintenance of p soria sis lesions. In our view, ho wever, it may be 
n ecessary to obtain more selected biopsy material to optimize 
identifi cation of the first activated lymphocyte populations in 
guttate psoriasis or the intraepidermallymphocyte populations in 
pl aq ue psoriasis. As outlined in Table I, sequential stages ha ve 
been proposed in the development of lympho cyte activation in 
psoriasis (Norris and Leung, 1997) . Psoriasis is recognized as a 
heterogenous disease;. the anti gens or superantigens that trigger 
or maintain psoriatic lesions through lymphocyte activation 
indeed may vary in difFe rent patients. The tissues analyzed in the 
two papers in this issue of JID may contain lymphocytes from 
multiple stages of activation, probably a combination of steps 2, 
3, and 4 . Other studies have used techniques to enrich cells in 
step 2 (Leung et al, 1995 b) or in step 4 (Chang et al, 1994). Once 
step 3 occurs in a lesion, the majority ofT lymphocytes in whole 
skin biopsies will probably represent recruited nonspecific lym-
phocytes . Even so, as show n in the paper by Vekony et a/, a 
signifi ca.nt proportion of "early" psoriasis lesions show som e VB 
skewing. These papers do not exclude the existence of superan-
tigen-activated lymphocytes identifi ed at th e not-yet-involved 
margins of gu ttate lesions by Leung eta/, the lymphocyte clones 
reactive to streptococci cloned b y Baker et a/, or the intraepi-
derm al CDS+ lymphocytes with clonal TCR expression identi-
fied by C han g et al. 
Regarding the efficiency of superantigens as inducers of psoriasis 
in animal models, it is likely that these potent immunologic stimuli 
m ay induce profound systemic and local effects, either directly or by 
cytoki.ne release, on lymphocytes, m onocytes, endothelial cells, and 
keratinocytes (Leung eta/, 1993; Norris and Leung, 1997). Many 
questions remain in detennin.i.ng the complex mechanism s of 
psoriasis and in particular lymphocyte activation in psoriasis. As 
suggested by Moss et a/, additional attention to other aspects of 
T -cell biology, such as trafftcki.ng, co- stimulati.on, or responses to 
cytoki.nes, is clearly warranted. In our view , however, the balance 
of data support the concept that lymphocyte proliferation and 
activation by superantigens or by classical intraepidenn al antigens 
remain in1portant components in the control oflymphocyte activa-
tion in psoriasis. 
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